Saltar al contenido
Merck

Expression of immunoproteasome subunits in the porcine lung: Alterations during normal and inflammatory conditions.

Veterinary microbiology (2017-11-07)
Qiang Liu, Yong-Li Zhang, Shou-Ping Hu, Ze-Lin Ma, Su-Li Gao, Bin Sun, Fei Xiao, Zhuo Zhang, Xue-Hui Cai, Xi-Jun He
RESUMEN

The elimination of infected cells by cytotoxic T lymphocytes (CTLs) occurs through interactions between T cell receptors (TCRs) and pathogen-derived antigenic peptide-major histocompatibility complex (MHC) class I complexes. The immunoproteasome (i-proteasome), which is a large proteolytic machine derived from the constitutive proteasome, is highly efficient at processing antigens for presentation on MHC class I molecules to activate CD8+ T lymphocytes; this in turn facilitates antiviral adaptive immune responses. To date, i-proteasome expression in the porcine lung has not been investigated. In this study, we systematically analyzed the expression of the i-proteasome in vivo in the porcine lung and in vitro in alveolar macrophages (AMs) under normal and inflammatory conditions such as with IFN-γ stimulation or PRRSV infection. AMs were shown to readily express low levels of i-proteasome subunits, which were confined to the cytoplasm and nucleus under normal conditions. While i-proteasome expression could also be detected in other lung parenchymal cells including alveolar type I and II cells and bronchial epithelial cells during inflammatory conditions. Results showed that i-proteasome expression is markedly increased in IFN-γ-stimulated AMs and PRRSV-infected lung tissue. In addition, PRRSV infection promoted i-proteasome expression in AMs during the early stage of infection, and this was independent of IFN-γ; expression was attenuated during the later stage of infection in vitro. These results suggested that i-proteasome subunit expression can be induced in the porcine lung, which facilitates the development of antiviral adaptive immune responses against intracellular infections. These results could facilitate the development of therapeutics that target intracellular pathogens.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
TWEEN® 20, viscous liquid
Sigma-Aldrich
Fluoroshield with DAPI, histology mounting medium
Sigma-Aldrich
TWEEN® 20, viscous liquid
AMDEX Goat Anti Rabbit IgG Horseradish Peroxidase Conjugate, Cytiva RPN4301